Analog Devices Foundation Donates $500,000 to Massachusetts General Hospital’s Vaccine & Immunotherapy Center (VIC) to Adva...
20 Abril 2020 - 9:00AM
Business Wire
ADI and MGH collaborate on sensing technologies
to enhance rapid disease testing and vital signs monitoring for
COVID-19 patients
Analog Devices, Inc. (Nasdaq: ADI) and The Analog Devices
Foundation, ADI’s charitable arm that advances its mission to
engineer a more sustainable future, announced today its recent
$500,000 donation to fund research at Massachusetts General
Hospital (MGH)’s Vaccine & Immunotherapy Center (VIC), directed
by Dr. Mark Poznansky MD, PhD.
The donation will directly support the VIC’s work to develop a
vaccine and novel point of care testing technologies for COVID-19,
which is critical to start opening up the economy and increase
safety of healthcare workers and their patients. Analog Devices and
the VIC are supporting a trial to develop and deploy two new tests
to identify and confirm which individuals have a detectable immune
response to COVID-19 and are virus negative. ADI and the VIC will
also seek ways to leverage ADI’s sensing technologies to develop
rapid care tests and real-time remote vital sign monitoring for
COVID-19 patients in quarantine.
“Analog Devices is proud to work with Massachusetts General
Hospital’s Vaccine & Immunotherapy Center as it works
tirelessly to discover the testing solutions required to identify
COVID-19 in individuals and slow the spread of the virus,” said
Vincent Roche, President and CEO of ADI. “There is no better
teammate in this fight than this prestigious medical research
institution and we look forward to working together to apply
sensing technology to testing and monitoring for COVID-19
patients.”
“We know that many individuals infected with COVID-19 have still
not been able to access testing to confirm the diagnosis,” said Dr.
Poznansky, MD, PhD, and Associate Professor of Medicine at Harvard
Medical School and Attending Physician in General and Transplant
Infectious Diseases at MGH. “Additionally, there are many others
who might have been infected but are unaware because they were
asymptomatic. Confirming immunity and viral negativity will be
critical to both beginning to help open up key sectors of society
and identifying those that can relatively safely interact amongst
others and those who should remain in quarantine.”
The MGH VIC was founded in 2008 to accelerate the translation of
laboratory discoveries into new, safe, and broadly applicable
cost-effective vaccines and therapies to prevent and cure various
forms of cancer, infectious and immune mediated diseases. VIC has
nine medical products currently in development and three have
entered human testing.
About Analog Devices
Analog Devices (Nasdaq: ADI) is a leading global
high-performance analog technology company dedicated to solving the
toughest engineering challenges. We enable our customers to
interpret the world around us by intelligently bridging the
physical and digital with unmatched technologies that sense,
measure, power, connect and interpret. Visit
http://www.analog.com
About Analog Devices Foundation
The Analog Devices Foundation is focused on supporting
organizations, initiatives and partnerships that advance its
mission to engineer a more sustainable future for our people and
planet. Through a variety of programs including matching community
gifts, volunteering gifts, and community grants, the Foundation
provides resources and monetary support to causes that advance
research, education and initiatives focused on protecting and
regenerating ecosystems, empowering people and their communities,
and helping tackle societal challenges.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200420005190/en/
Editor's Contact Information Ms. Andrea Duffy
646-984-0240 Andrea.Duffy@teneo.com
Analog Devices (NASDAQ:ADI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Analog Devices (NASDAQ:ADI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024